Compositions and methods of nucleic acid-targeting nucleic acids

Inventors

May, Andrew Paul • Haurwitz, Rachel E. • DOUDNA, Jennifer A. • Berger, James M. • Carter, Matthew Merrill • Donohoue, Paul Daniel

Assignees

Caribou Biosciences Inc

Interested in licensing this patent?

MTEC can help explore whether this patent might be available for licensing for your application.

Publication Number

US-11312953-B2

Patent

Publication Date

2022-04-26

Expiration Date


Abstract

This disclosure provides for compositions and methods for the use of nucleic acid-targeting nucleic acids and complexes thereof.

Core Innovation

The invention relates to engineered Type II CRISPR single guide RNA capable of forming a complex with a Type II CRISPR Cas9 protein. The engineered single guide RNA includes a spacer sequence capable of hybridizing to a target nucleic acid sequence and an sgBackbone consisting of a minimum CRISPR repeat sequence, a single guide connector sequence, a minimum tracrRNA sequence, and a 3′ tracrRNA sequence.

A central aspect is that the sgBackbone is encoded by defined sequences selected from SEQ ID Nos: 1471 and 1474, or by sequences consisting of SEQ ID NO: 1469 or SEQ ID NO: 1470, as recited in the independent claims. The disclosure also describes engineered nucleic acid-targeting nucleic acids with modified bulge structures and altered binding dissociation constants (Kd) to a site-directed polypeptide.

The document further states that modified guides can target new PAMs and polypeptides and cleave target nucleic acids when complexed with a nuclease, including Cas9. Broader genome engineering and downstream applications are discussed, including insertions and barcoding using donor polynucleotide delivery, assessment workflows comparing NHEJ versus HR, and sequencing/enrichment systems.

Claims Coverage

The independent claims define engineered Type II CRISPR single guide RNAs that can form a complex with a Type II CRISPR Cas9 protein, with inventive features focused on a defined spacer-plus-sgBackbone architecture and restriction of the sgBackbone to specific SEQ ID sequences. Two independent claims are present.

Type II CRISPR single guide RNA with defined sgBackbone encoding (SEQ ID Nos: 1471 and 1474)

An engineered Type II CRISPR single guide RNA comprising a spacer sequence capable of hybridizing to a target nucleic acid sequence and an sgBackbone consisting of a minimum CRISPR repeat sequence, a single guide connector sequence, a minimum tracrRNA sequence, and a 3′ tracrRNA sequence, wherein the sgBackbone is encoded by a sequence selected from the group consisting of SEQ ID Nos: 1471 and 1474.

Type II CRISPR single guide RNA with defined sgBackbone encoding (SEQ ID Nos: 1469 or 1470)

An engineered Type II CRISPR single guide RNA comprising a spacer sequence capable of hybridizing to a target nucleic acid sequence and an sgBackbone consisting of a minimum CRISPR repeat sequence, a single guide connector sequence, a minimum tracrRNA sequence, and a 3′ tracrRNA sequence, wherein the sgBackbone is encoded by a sequence consisting of SEQ ID NO: 1469 or SEQ ID NO: 1470.

Across the independent claims, the core claim coverage centers on engineered Type II CRISPR single guide RNAs that form a complex with a Type II CRISPR Cas9 protein, using a spacer for target hybridization and an sgBackbone defined by specific minimum repeat, connector, and tracrRNA regions with the sgBackbone encoding restricted to the enumerated SEQ ID sequences.

Stated Advantages

Not explicitly described in patent.

Documented Applications

Genome engineering applications including donor delivery for insertions and barcoding are described.

Target nucleic acid cleavage when guides are complexed with a nuclease, including Cas9.

Assessment workflows comparing NHEJ versus HR, including cleavage and quantification readouts.

Sequencing/enrichment systems for measurements, including sequence enrichment without amplification and NIP-Seq/nuclease immunoprecipitation and sequencing.

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.